Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital | Scientific Reports
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf
3HP for Latent TB Infection Treatment | CDC
Treatment of latent tuberculosis infection | Semantic Scholar
4 months of rifampin for latent TB shows promise
Treatment for Latent TB Infection in Adults | Download Table
Treatment Regimens for Latent TB Infection | TB | CDC
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other
What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Treatment For Latent TB(Tuberculosis) Infection Isoniazid (INH) | The Windsor-Essex County Health Unit
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection | NEJM
Tuberculosis: Current Treatments and Investigational Therapies
Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article
Table 3 from Treatment of Latent Tuberculosis Infection. | Semantic Scholar
3HP for Latent TB Infection Treatment | CDC
Dosing regimens for tuberculosis | Download Table
12-dose Isoniazid (INH)/Rifapentine Regimen (3HP) for Treatment of Latent TB Intection (LTBI)